Estrogen patches with ARPIs confirmed comparable PSA responses and security in comparison with LHRHa plus ARPIs in metastatic prostate most cancers, per STAMPEDE...
Regeneron’s BLA resubmission for linvoseltamab, a possible remedy for relapsed/refractory a number of myeloma, is underneath FDA assessment.For adults with relapsed or refractory...
Up to date knowledge from research like EV-302 and CheckMate 274 have been offered on the 2025 ASCO Genitourinary Cancers Symposium, reinforcing the...
Though carbon ion radiation led to a decline in urinary perform amongst sufferers with prostate most cancers, perform returned to regular after three...
